Berman Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Berman Capital Advisors’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$11K	Buy
2019 Q3	–	Sell
2019 Q2	$9K	Buy